Pfizer said on Friday it would apply for emergency use in the U.S. of its Covid-19 vaccine candidate as soon as a safety milestone is achieved in the third week of November.
Pfizer sees emergency use filing for COVID-19 vaccine after U.S. election https://t.co/R6tumgvcBT pic.twitter.com/ZixX4EJ1Hi
— Reuters (@Reuters) October 16, 2020